Company type | Private |
---|---|
Industry | Agrobusiness, chemicals |
Founded | 13 November 2000 |
Headquarters | Basel, Switzerland |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$19.963 billion (2022) |
Net income | US$1.907 billion (EBITDA) (2022) |
Owner | Sinochem |
Divisions |
|
Website | www |
Footnotes / references Financial Report 2022 |
Syngenta is a provider of agricultural science and technology, in particular seeds and pesticides with its management headquarters in Basel, Switzerland.[1] It is part of Syngenta Group, entirely owned by Sinochem, a Chinese state-owned enterprise.[2]
Syngenta was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca, and acquired by China National Chemical Corporation (ChemChina) in 2017.[3] Its business units are Syngenta Crop Protection and Syngenta Seeds. In 2020, the Syngenta Group was formed, bringing together Syngenta Crop Protection and Syngenta Seeds, Adama, and the agricultural business of Sinochem, now called Syngenta Group China, under a single entity.[4]
Syngenta's primary products include pesticides, selective herbicides, non-selective herbicides, fungicides, insecticides, as well as corn, soya, and biofuel. Syngenta brands include Actara (Thiamethoxam), Agrisure (corn with Viptera trait), Alto (Cyproconazole), Amistar (azoxystrobin), Avicta, Axial, Bicep II, Bravo, Callisto, Celest, Cruiser (TMX, Thiamethoxam), Dividend, Dual, Durivo, Elatus, Fusilade, Force, Golden Harvest, Gramoxone, Karate, Northrup-King (NK), Proclaim, Revus, Ridomil, Rogers, Score, Seguris, S&G, Tilt, Topik, Touchdown, Vertimec and Vibrance.
The 2011 Dow Jones Sustainability Index, named Syngenta one of the best performing chemical companies worldwide. However, the company has been controversial, mainly due to its main business – selling toxic chemicals and the environmental impact of those chemicals – but also due to its investment in lobbying. In 2012, the company was nominated for the Public Eye Award, which denounces companies with questionable human rights practices.